Kinetics of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor
Biologic drugs are large molecule pharmaceuticals that do not cross the blood-brain barrier (BBB), which is formed by the brain capillary endothelium. Biologics can be re-engineered for BBB transport as IgG fusion proteins, where the IgG domain is a monoclonal antibody (MAb) that targets an endogeno...
Saved in:
Main Author: | William M. Pardridge (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
by: William M. Pardridge, et al.
Published: (2021) -
Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
by: Maj Schneider Thomsen, et al.
Published: (2022) -
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
by: William M. Pardridge
Published: (2023) -
Antibody-mediated targeting of the transferrin receptor in cancer cells
by: Rosendo Luria-Pérez, et al.
Published: (2016) -
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
by: Maria João Ramalho, et al.
Published: (2022)